# 8-K filed: Aspire Biopharma Holdings, Inc.

> sec 8k · VERIFIED · 2026-08-10

Filed: 2026-08-10 AccNo: 0001493152-26-036777 Size: 597 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

- Company: Aspire Biopharma Holdings, Inc.
- Sector: biotech
- Primary source: https://www.sec.gov/Archives/edgar/data/1847345/000149315226036777/0001493152-26-036777-index.htm

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.